Connect with us

National

Trans visibility, LGBTQ progress in military on display at DOD Pride event

Published

on

Bree Fram, transgender troops, gay news, Washington Blade
Lt. Col. Bree Fram was among the speakers at the annual DOD Pride event.

Transgender visibility in the U.S. military was on full display on Tuesday during the Pentagon’s annual event recognizing Pride month, which this year featured two transgender speakers in prominent positions in the aftermath of the Biden administration lifting the transgender military ban.

The event — hosted in coordination with DOD Pride, the affinity group for LGBTQ employees and service members within the Defense Department — took place in the Pentagon auditorium under the theme of “All Together” and highlighted progress in stripping away barriers previously preventing LGBTQ people from serving in their roles, such as “Don’t Ask, Don’t Tell” and the transgender military ban.

Lt. Col. Bree Fram, who’s transgender and deputy chief of acquisition polices and processes at U.S. Space Force, said she often feared she would no longer be able to serve in uniform based on the “whim of executive orders.” But two months ago when she disclosed to colleagues she was having surgery to treat cancer, she received overwhelming support.

“That’s the spirit of all together: Leadership was behind me because they would have been behind any member of the team going through one of the scariest moments of their life,” Fram said. “They know that each of us brings value to the team and that all of us are worthy of the support needed to be our best selves.”

Fram, co-leader of the transgender policy team within the Department of the Air Force’s LGBTQ initiative team, recounted the experience of a transgender service member whose colleagues refused to use her personal pronouns and began putting them in her email signature in defiance of military policy. Although colleagues had initially sought to ban her from the network, Fram said a supervisor stepped in to revise and allow the service members to continue using them in emails.

“So for all of you out there, I ask you to set out your symbols of pride, share your pronouns in your email, particularly if you’re a person who doesn’t think they need to,” Fram said. “Initiate difficult conversations about racial and gender barriers and share a bit of your vulnerability in a way that draws others in.”

Shawn Skelly, who’s transgender and assistant secretary of defense for readiness, also spoke and drew heavily from President Biden’s proclamation for Pride month to discuss the challenges still facing LGBTQ people after years of progress.

“America’s formative promise to itself remains today tangibly unfulfilled for too many Americans,” Skelly said. “And remarkably, for the LGBTQ+ Americans of today, we’re increasingly at specific, targeted risk, which includes those serving within this department.”

Under Secretary of the Air Force Gina Ortiz Jones, who’s a lesbian, also spoke and remarked on the progress seen in the military since she was forced to sign a document as a cadet of “Don’t Ask, Don’t Tell” prohibiting her from participating in homosexual acts.

“I knew exactly what that meant: I knew that my opportunity to get an education. I knew that my opportunity to serve our country. I knew my opportunity to die for our country or maybe all of that would go away, just because at the time we did not have enough leaders with the courage to say anybody ready and willing to serve their country should have the opportunity to do so,” Jones said.

Jones recounted a story after she took office in the Biden administration and wanted to set up a photo shoot with other LGBTQ service members who had served under “Don’t Ask, Don’t Tell.” To her surprise on the day of the shoot, Jones said, many younger service members too young to remember the law showed up and were part of the photograph.

“But I leaned over and I said, ‘Hey, you know, what’s going on here? Some of these folks look a little too young to serve,”” Jones said. “And they said, ‘Oh no, many of these folks wanted to be part of the picture because they are serving because ‘Don’t Ask Don’t Tell’ was repealed … So it really shows you what is possible when you’re willing to do the hard work that talent in our country among those serving — the talent we are able to tap into — if we are willing to remove those barriers to ensure folks can serve to their full potential.”

The top defense official present was Kathleen Hicks, who promoted the Defense Department as having a commitment to advancing policies and programs aimed at developing “a leadership pipeline of diverse talent and create pathways for everyone at DOD to realize their potential.”

“We know that organizational climates affect our workforces’ experiences,” Hicks said. “More to the point it affects our warrior readiness. Therefore, we are directing initiatives to improve leader skill development and foster more effective inclusive team environments.”

Hicks said the Defense Department is in the final stages of developing a diversity, equity, inclusion and accessibility plan, which she said will direct activities within the department and identify priorities within the coming year.

Among those in attendance at the event were British Ambassador to the United States Karen Price; Secretary of the Navy Carlos del Toro; Rep. Mark Takano (D-Calf.); Maj. Gen. Leah Lauderback, director of intelligence, surveillance and reconnaissance for U.S. Space Force; White House Director of Presidential Personnel Gautam Raghavan; and Ruben Gonzalez, special assistant to the president for White House Domestic Agency Personnel.

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

U.S. Supreme Court

Nine trans activists arrested outside Supreme Court

Gender Liberation Movement organized demonstration against Skrmetti ruling

Published

on

Protest sign outside of the U.S. Supreme Court on June 18, 2025. (Washington Blade photo by Michael Key)

On Friday afternoon, nine transgender organizers and allies were arrested on the steps of the U.S. Supreme Court for blocking the street and protesting the recent U.S. v. Skrmetti ruling.

The ruling, decided 6-3 by the conservative majority on Wednesday, upheld Tennessee’s ban on gender-affirming care for minors. The decision will allow states to pass laws restricting gender-affirming care for minors and further minimizes bodily autonomy.

The nine arrested were part of a larger group of more than 30 protesters wearing colors of the trans Pride flag— pink, blue, and white, — standing outside of the nation’s highest court. Organizers unfurled large cloths in pink, blue, and white, shared personal testimonies about how their gender-affirming care was a matter of life and death, released pink and blue smoke, and saw nine trans participants take their hormone replacement therapy.

The protest was led by the Gender Liberation Movement, an organization that “builds direct action, media, and policy interventions centering bodily autonomy, self-determination, the pursuit of fulfillment, and collectivism in the face of gender-based sociopolitical threats.” Among the nine arrested was GLM co-founder Raquel Willis.

Before being arrested, Willis spoke to multiple media outlets, explaining that this decision was an overreach of power by the Supreme Court.

“Gender-affirming care is sacred, powerful, and transformative. With this ruling in U.S. v. Skrmetti, we see just how ignorant the Supreme Court is of the experiences of trans youth and their affirming families,” said Willis. “Everyone deserves the right to holistic healthcare, and trans youth are no different. We will continue to fight for their bodily autonomy, dignity, and self-determination just like previous generations. No court, no law, no government gave us our power, and none can take it away.”

GLM co-founder Eliel Cruz also spoke to media outlets about the Skrmetti ruling, calling it “a historical moment of fascist attacks,” and encouraged the LGBTQ community to “organize and fight back.”

“As a cisgender man, I stand in solidarity with the trans community during these escalating attacks on their safety, well-being, right to exist in this world, and ability to live a future free of violence,” Cruz said. “I’m enraged at the Supreme Court’s decision to uphold a ban on gender-affirming care for youth. My heart hurts for the families and young people who this will negatively impact and harm.”

The Washington Blade reached out to Capitol Police for comment.

A spokesperson said the nine activists were arrested for violating D.C. Code §22-1307 — “Crowding, Obstructing, or Incommoding” — on First Street, N.E., after receiving three warnings.

Continue Reading

National

FDA approves new twice-yearly HIV prevention drug

Experts say success could inhibit development of HIV vaccine

Published

on

New HIV prevention drug Lenacapavir replaces oral medicines with twice-yearly injections. (Photo by fet/Bigstock)

The U.S. Food and Drug Administration (FDA) on June 18 approved a newly developed HIV/AIDS prevention drug that only needs to be taken by injection once every six months.

The new drug, lenacapavir, which is being sold under the brand name of Yeztugo by the pharmaceutical company Gilead Sciences that developed it, is being hailed by some AIDS activists as a major advancement in the years-long effort to end the HIV/AIDS epidemic in the U.S. and worldwide.

Although HIV prevention drugs, known as pre-exposure prophylaxis medication or PrEP, have been available since 2012, they initially required taking one or more daily pills. More recently, another injectable PrEP drug was developed that required being administered once every two months.

Experts familiar with the PrEP programs noted that while earlier drugs were highly effective in preventing HIV infection – most were 99 percent effective – they could not be effective if those at risk for HIV who were on the drugs did not adhere to taking their daily pills or injections every two months. Experts also point out that large numbers of people at risk for HIV, especially members of minority communities, are not on PrEP and efforts to reach out to them should be expanded.

“Today marks a monumental advance in HIV prevention,” said Carl Schmid, executive director of the D.C.-based HIV + Hepatitis Policy Institute, in a statement released on the day the FDA announced its approval of lenacapavir.

“Congratulations to the many researchers who spent 19 years to get to today’s approval, backed up by the long-term investment needed to get the drug to market,” he said.

Schmid added, “Long-acting PrEP is now not only effective for up to six months but also improves adherence and will reduce HIV infections – if people are aware of it and payers, including private insurers, cover it without cost-sharing as a preventive service.”

Schmid and others monitoring the nation’s HIV/AIDS programs have warned that proposed large scale cuts in the budget for the U.S. Centers for Disease Control and Prevention by the administration of President Donald Trump could seriously harm HIV prevention programs, including PrEP-related efforts.

“Dismantling these programs means that there will be a weakened public health infrastructure and much less HIV testing, which is needed before a person can take PrEP,” Schmid said in his statement.

“Private insurers and employers must also immediately cover Yeztugo as a required preventive service, which means that PrEP users should not face any cost-sharing or utilization management barriers,” he said.

In response to a request by the Washington Blade for comment,  a spokesperson for Gilead Sciences released a statement saying the annual list price per person using Yeztugo in the U.S. is $28,218. But the statement says the company is working to ensure that its HIV prevention medication is accessible to all who need it through broad coverage from health insurance companies and some of its own support programs.

“We’ve seen high insurance coverage for existing prevention options – for example, the vast majority of consumers have a $0 co-pay for Descovy for PrEP in the U.S. – and we are working to ensure broad coverage for lenacapavir [Yeztugo],” the statement says. It was referring to the earlier HIV prevention medication developed by Gilead Sciences, Descovy.

“Eligible insured people will get help with their copay,” the statement continues. “Gilead’s Advancing Access Copay Savings Program may reduce out-of-pocket costs to as little as zero dollars,” it says. “Then for people without insurance, lenacapavir may be available free of charge for those who are eligible, through Gilead’s Advancing Access Patient Assistance Program.”

Gilead Sciences has announced that in the two final trial tests for Yeztugo, which it describes as “the most intentionally inclusive HIV prevention clinical trial programs ever designed,” 99.9 percent of participants who received Yeztugo remained negative. Time magazine reports that among those who remained HIV negative at a rate of 100 percent were men who have sex with men. 

Time also reports that some HIV/AIDS researchers believe the success of the HIV prevention drugs like Gilead’s Yeztugo could complicate the so-far unsuccessful efforts to develop an effective HIV vaccine. 

To be able to test a potential vaccine two groups of test subjects must be used, one that receives the test vaccine and the other that receives a placebo with no drug in it. 

With highly effective HIV prevention drugs now available, it could be ethically difficult to ask a test group to take a placebo and continue to be at risk for HIV, according to some researchers. 

“This might take a bit of the wind out of the sails of vaccine research, because there is something so effective in preventing HIV infection,”  Time quoted Dr. David Ho, a professor of microbiology, immunology, and medicine at New York’s Columbia University as saying.

Continue Reading

National

Activists rally in response to Supreme Court ruling

‘We won’t bow to hatred: we outlive it’

Published

on

Hope Giselle-Godsey speaks at a rally for trans rights at the Lutheran Church of the Reformation on Wednesday, June 18. (Washington Blade photo by Michael Key)

Politicians, LGBTQ activists, and allies gathered at the Lutheran Church of the Reformation in the Capitol Hill neighborhood of Washington, D.C. on Wednesday following the ruling by the United States Supreme Court in the case of U.S. v. Skrmetti. The Supreme Court upheld a Tennessee ban on gender-affirming healthcare for transgender adolescents in a 6-3 decision.

A rally outside the U.S. Supreme Court was called for by the American Civil Liberties Union, Lambda Legal and other organizations following the high court ruling on Wednesday. However, due to a thunderstorm and flood watch, the scores of activists who were to attend the rally were directed to a Lutheran church down the street from the court. Undeterred, activists and community leaders were joined by U.S. Senators Ed Markey (D-Mass.) and Jeff Merkley (D-Ore.) for an indoor rally at the church.

“We know that freedom is not inevitable,” Markey told the crowd. “It is fought for by people who said ‘no’ in the face of health cuts, ‘no’ in the face of discrimination, ‘no’ in the face of invasive laws that ban life-saving and life-affirming healthcare and ‘no’ to this anti-justice, anti-freedom agenda.”

Also speaking at the rally was Deirdre Schifeling, chief political advocacy officer of the National ACLU.

“We believe transgender rights matter,” Schifeling stated. “Transgender kids matter and deserve love, support and the freedom to shape their own futures. I am still processing how the Supreme Court could disagree with such an obvious truth.”

“Today’s ruling shows us that unfortunately these attacks on our freedom will not end here,” Schifeling continued. “The Trump administration and extremist politicians across the country are continuing to target our right — our human right — to control our own bodies.”

“If politicians think that we are going to sit back and be defeated, that we are going to let them strip our rights and freedoms away without a fight, they’ve got another think coming,” Schifeling said. “We will never back down. We will never back down or give up. We will organize, we will mobilize and we will fight to protect trans rights in our communities, in our legislatures, in our elections, and in court rooms across the country.”

(Washington Blade photo by Michael Key)

“Today, the highest court in this land decided that the bodily autonomy of trans youth, specifically trans youth of Tennessee and states with bans harming youth across the country do not matter,” said trans advocate Hope Giselle-Godsey.

“The opponents of trans equality think that today is a victory, but history will remember it as a moment that sharpened us and not silenced us,” Giselle-Godsey continued.

“So yes, today we grieve for the people in those states where those bans exist, but we grieve in motion,” Giselle-Godsey said. “To the system that thinks that it won today, just like every other time before: you will lose again. Because we won’t bow to hatred: we outlive it. We out-organize it. We out-love it. We are still here and we are not finished yet.”

‘As we proceed, the most important pressure here is from the people,’ U.S. Sen. Jeff Merkley (D-Ore.) tells a crowd of trans rights activists at the Lutheran Church of the Reformation on Wednesday, June 18. (Washington Blade photo by Michael Key)
Continue Reading

Popular